Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 6/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14024787 | 0.98 | KDM4E (0.58) | CNR1KDM4ESOAT1NFKB1NFKB2 | |
| SCHEMBL31650510 | 0.94 | FAAH (0.50) | CNR1KDM4ESOAT1NFKB1NFKB2 | |
| SCHEMBL1657170 | 0.94 | FAAH (0.50) | CNR1KDM4ESOAT1NFKB1NFKB2 | |
| SCHEMBL31650568 | 0.94 | FAAH (0.50) | CNR1KDM4ESOAT1NFKB1NFKB2 | |
| SCHEMBL1657168 | 0.94 | FAAH (0.50) | CNR1KDM4ESOAT1NFKB1NFKB2 | |
| SCHEMBL11861121 | 0.92 | CNR1 (0.56) | CNR1KDM4ESOAT1TRPV1PPARG | |
| SCHEMBL11861129 | 0.92 | CNR1 (0.56) | CNR1KDM4ESOAT1TRPV1PPARG | |
| SCHEMBL1658545 | 0.92 | FAAH (0.53) | KDM4ESOAT1TRPV1PPARG | |
| SCHEMBL1658543 | 0.92 | FAAH (0.53) | KDM4ESOAT1TRPV1PPARG | |
| SCHEMBL6439344 | 0.92 | FAAH (0.48) | CNR1KDM4ESOAT1NFKB1NFKB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226002-A1 | RETINAL BIOAVAILBILITY OF SYNTHETIC VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226002-A1 | RETINAL BIOAVAILBILITY OF SYNTHETIC VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS | ELOVL1, ELOVL3, FFAR2 | CNR1 2140/4885KDM4E 4590/4885SOAT1 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.